CEACAM5 and colorectal carcinoma: Currently, serum carcinoembryonic antigen (CEA) has been widely used in the diagnosis and prognosis assessment of CRC and has easy, rapid, and minimal invasion and other advantages, but its sensitivity and specificity are insufficient [5, 6].